We are live on
!
Find out more
ASA
Armstrong Shaw Associates Portfolio holdings
AUM
$95.2M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$466M
AUM Growth
-$86.3M
(-16%)
Cap. Flow
-$89.6M
Cap. Flow
% of AUM
-19.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
42
New
1
Increased
3
Reduced
31
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$7.2M |
| 2 |
AbbVie
ABBV
|
+$2.05M |
| 3 |
Delta Air Lines
DAL
|
+$1.04M |
| 4 |
Microsoft
MSFT
|
+$152K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$11.4M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$8.14M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$7.37M |
| 4 |
CVS Health
CVS
|
+$4.32M |
| 5 |
Halliburton
HAL
|
+$4.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.54% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.98% |
| 4 | Technology | 9.91% |
| 5 | Consumer Discretionary | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CVS Health
CVS
$137B
| $26M | 5.57% |
251,533
-42,654
| -14% | -$4.32M |
|
|
2
Delta Air Lines
DAL
$55.9B
| $20.8M | 4.45% |
461,783
+22,322
| +5% | +$1.04M |
|
|
CMCSK
3
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $19.8M | 4.24% |
352,735
-62,709
| -15% | -$3.52M |
|
4
Elevance Health
ELV
$81.9B
| $18.1M | 3.88% |
117,170
-21,008
| -15% | -$2.99M |
|
5
Honeywell
HON
$77B
| $16.4M | 3.51% |
174,723
-2,909
| -2% | -$266K |
|
6
JPMorgan Chase
JPM
$939B
| $16.3M | 3.49% |
268,406
-44,940
| -14% | -$2.66M |
|
7
American International
AIG
$41.9B
| $16M | 3.42% |
291,319
-50,139
| -15% | -$2.69M |
|
8
Capital One
COF
$124B
| $15.9M | 3.42% |
202,260
-33,748
| -14% | -$2.65M |
|
9
Ford
F
$57.3B
| $15.9M | 3.42% |
987,762
-171,926
| -15% | -$2.71M |
|
|
HOUS
10
DELISTED
Anywhere Real Estate
HOUS
| $15.6M | 3.35% |
343,247
-61,849
| -15% | -$2.85M |
|
11
Wells Fargo
WFC
$261B
| $15.5M | 3.32% |
284,240
-51,947
| -15% | -$2.81M |
|
12
Intercontinental Exchange
ICE
$82.4B
| $14.8M | 3.18% |
318,000
-55,245
| -15% | -$2.49M |
|
|
CPN
13
DELISTED
Calpine Corporation
CPN
| $14M | 3.01% |
613,046
-102,794
| -14% | -$2.22M |
|
|
14
Microsoft
MSFT
$2.84T
| $13.8M | 2.96% |
339,397
+3,491
| +1% | +$152K |
|
15
Chubb
CB
$140B
| $13.7M | 2.95% |
123,288
-21,583
| -15% | -$2.43M |
|
16
Travel + Leisure Co
TNL
$4.54B
| $13.4M | 2.88% |
329,074
-57,468
| -15% | -$2.29M |
|
17
Sensata Technologies
ST
$6.65B
| $13.4M | 2.87% |
232,696
-41,560
| -15% | -$2.21M |
|
|
18
AbbVie
ABBV
$458B
| $13.1M | 2.82% |
224,287
+33,920
| +18% | +$2.05M |
|
19
RTX Corp
RTX
$287B
| $13.1M | 2.81% |
177,817
-41,525
| -19% | -$3.1M |
|
20
UnitedHealth
UNH
$382B
| $13M | 2.79% |
109,958
-18,366
| -14% | -$2.04M |
|
21
MetLife
MET
$61B
| $12.7M | 2.73% |
282,585
-48,689
| -15% | -$2.19M |
|
22
Thermo Fisher Scientific
TMO
$211B
| $12.5M | 2.68% |
92,869
-16,365
| -15% | -$2.11M |
|
23
Amgen
AMGN
$203B
| $12.1M | 2.6% |
75,740
-14,354
| -16% | -$2.26M |
|
24
Goldman Sachs
GS
$313B
| $11.8M | 2.53% |
62,865
-11,048
| -15% | -$2.05M |
|
25
Air Products & Chemicals
APD
$66.3B
| $11.7M | 2.52% |
83,835
-15,047
| -15% | -$2.08M |
|
Similar funds
AEPLI
GG
VI
TAM
WCM
QT
OC
KC
Armstrong Shaw Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Armstrong Shaw Associates held 42 positions worth $466M, down 16% from $553M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Armstrong Shaw Associates withdrew a net $89.6M in Q1 2015, closing 2 positions and reducing 31 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $8.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Armstrong Shaw Associates opened a new position in Capri Holdings worth $6.9M.
- Armstrong Shaw Associates's largest Q1 2015 buy was Capri Holdings: 104,935 shares worth $6.9M.
- Armstrong Shaw Associates added most to AbbVie in Q1 2015, an estimated $2.05M increase.
- Armstrong Shaw Associates's biggest Q1 2015 reduction was DuPont de Nemours, cutting an estimated $11.4M.
- Armstrong Shaw Associates fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $8.14M.
- Armstrong Shaw Associates's ten largest holdings make up 39% of its $466M portfolio in Q1 2015.
- Armstrong Shaw Associates opened 1 new position and closed 2 in Q1 2015.
- Armstrong Shaw Associates's portfolio value fell 16% quarter-over-quarter to $466M.
Based on Armstrong Shaw Associates's 13F filing for Q1 2015, filed 11 May 2015.